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Abstract Dexamphetamine (dAMPH) is not only used for
the treatment of attention deficit hyperactivity disorder
(ADHD), but also as a recreational drug. Acutely, dAMPH
induces release of predominantly dopamine (DA) in the stria-
tum, and in the cortex both DA and noradrenaline. Recent
animal studies have shown that chronic dAMPH administra-
tion can induce changes in the DA system following long-
term exposure, as evidenced by reductions in DA transporters,
D2/3 receptors and endogenous DA levels. However, only a
limited number of studies have investigated the effects of
dAMPH in the human brain. We used a combination of
resting-state functional magnetic resonance imaging
(rs-fMRI) and [123I]IBZM single-photon emission computed
tomography (SPECT) (to assess baseline D2/3 receptor bind-
ing and DA release) in 15 recreational AMPH users and 20
matched healthy controls to investigate the short-, and long-
term effects of AMPH before and after an acute intravenous
challenge with dAMPH.We found that acute dAMPH admin-
istration reduced functional connectivity in the cortico-striatal-
thalamic network. dAMPH-induced DA release, but not DA
D2/3 receptor binding, was positively associated with connec-
tivity changes in this network. In addition, acute dAMPH
reduced connectivity in default mode networks and salience-
executive-networks networks in both groups. In contrast to
our hypothesis, no significant group differences were found
in any of the rs-fMRI networks investigated, possibly due to
lack of sensitivity or compensatory mechanisms. Our findings
thus support the use of ICA-based resting-state functional
connectivity as a tool to investigate acute, but not chronic,
alterations induced by dAMPH on dopaminergic processing
in the striatum.
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Introduction
Dopamine (DA) neurotransmission plays a key role in regu-
lating motor function, motivation and reward, cognition, and
impulsive behavior by modulating oscillations in cortico-
striatal-thalamic (CST) networks (Walters et al. 2000). The
striatum receives widespread input from the frontal cortex
and dopaminergic projections are abundant in this network.
DA is thought to modulate cortico-striatal connection strength
by increasing the signal-to-noise ratio within these loops
(Bamford et al. 2004). Studies using electroencephalography
(EEG) and task functional magnetic resonance imaging
(fMRI) have also suggested that functional connectivity (FC)
in the CST loops could be strongly modulated by dopaminer-
gic neurotransmission (Honey et al. 2003; Williams et al.
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2002). Converging evidence reveals that oscillations at the
network level can also be assessed with resting-state fMRI
(rs-fMRI). For instance, recent animal studies have shown that
acute changes in DA concentrations contribute to the regula-
tion of functional connectivity (FC) in the brain. For example,
acute administration of the potent psychostimulant
dexamphetamine (dAMPH), which increases extracellular
DA concentrations by releasing DA and blocking its
re-uptake, increased connectivity within the mesolimbic pro-
jections of the ventral tegmental area to the ventral forebrain
and dorsal thalamic structures of rats (Schwarz et al. 2007).
The effect of acute dAMPH on functional connectivity in the
CST loops has not been investigated in humans, but acute
administration of other dopaminergic stimulant drugs such
as methylphenidate (MPH) has been shown to alter CST FC
as measured with rs-fMRI (Mueller et al. 2014; Ramaekers
et al. 2013; Sripada et al. 2013), as well as in other resting state
networks (RSNs), such as the default mode network (DMN)
and salience-executive networks (SENs).
Not only the acute effects of dAMPH in humans are poorly
understood, studies on the effects of chronic AMPH use on the
DA system are also scarce. This is important, since AMPH is
used recreationally, and prescribed for treatment of neuropsy-
chiatric disorders such as attention deficit hyperactivity disor-
der (ADHD) and narcolepsy (Heal et al. 2013). Several animal
studies have shown that chronic dAMPH administration in-
duces long-lasting changes to the DA system, such as a reduc-
tion in the number of DA transporters (DATs), vesicular mono-
amine transporters type 2 (VMAT2), DA D2/3 receptors and
DA release (Berman et al. 2009; McCann and Ricaurte 2004;
Ricaurte et al. 2005). The few studies that have been conducted
in humans reported lower striatal DAT binding and reduced
striatal DA release in response to acute dAMPH administration
(Schrantee et al. 2014; Reneman et al. 2002) in chronic AMPH
users. However, so far, no rs-fMRI studies have been conduct-
ed in chronic AMPH users. Nonetheless, a recent study in
methamphetamine (METH) users reported increased connec-
tivity in the mesocorticolimbic system in METH dependent
subjects when compared with controls (Kohno et al. 2014).
More studies have investigated resting-state FC (RS FC) in
cocaine-dependent subjects but the results are inconsistent,
with both increases and decreases in connectivity having been
reported (e.g. Gu et al. 2010; Camchong et al. 2011).
Therefore, the aim of this study was to investigate both the
acute and chronic effects of AMPH on resting-state FC in
humans, by means of studying recreational AMPH users and
healthy controls. Given dAMPH’s strong effects on striatal
DA levels, and the findings of previous studies with MPH,
we hypothesized that acute dAMPH would modulate CST
connectivity and that chronic AMPH users would demonstrate
lower change in FC in this network when compared to con-
trols. Because it has been shown that FC within RSNs is
strongly associated with DA D2/3 receptor expression (Cole
et al. 2012; Sambataro et al. 2013), we also investigated
whether variations in the individual’s DA neurotransmitter
system predict individual RSN FC. [123I]IBZM single photon
emission computed tomography (SPECT) was used to mea-
sure DAD2/3 receptor expression and endogenousDA release.
[123I]IBZM, a selective antagonist for the D2/3 receptor, com-
petes with endogenous DA for receptor binding and a DA
stimulus such as dAMPH can induce a displacement of
[123I]IBZM binding that is inversely associated with DA re-
lease (Kegeles et al. 1999).
Although we have a strong neurochemical hypothesis to
study alterations in the CST network, previous studies have
also suggested other networks to be modulated by DA-ergic
drugs (Cole et al. 2013). Therefore, we examined the acute
and chronic effects of AMPH on the executive, default mode




Sixteen male AMPH users and age-, gender- and IQ-matched
controls were recruited through online advertisements and
flyers at local universities and colleges. Inclusion criteria for
the AMPH users were at least 30 occasions of use lifetime.
The 20 control subjects were healthy volunteers with no self-
reported prior use of AMPH or other drugs that affect the
dopaminergic system. Exclusion criteria for all participants
were a history of a chronic neurological or psychiatric disor-
der, family history of sudden heart failure, current use of psy-
choactive medication, abnormal electrocardiogram (ECG),
positive drug screen, and a clinical diagnosis of ADHD, in
addition to smoking more than 15 cigarettes per day, drinking
more than 30 alcoholic beverages per week, and contraindica-
tions for undergoing an MRI scan (e.g. ferromagnetic frag-
ments) or the SPECT procedure (e.g. allergy to iodine). The
results of the SPECT study in this cohort are more elaborately
reported elsewhere (Schrantee et al. 2014). Participants agreed
to abstain from smoking, caffeine, alcohol and cannabis for
24 h prior, and for other drugs (including AMPH) one week
prior to the assessments. Subjects were asked on the day of the
scan if they had used any of these substances in the past two
weeks. We verified the reported drug use with a drug screen
on a urine sample with an enzyme-multiplied immunoassay
for amphetamines, cocaine metabolite, opiates and marijua-
na). In addition, a detailed drug history questionnaire was
obtained and subjects filled in the drug use disorders identifi-
cation test (DUDIT) to assess substance dependence (Voluse
et al. 2012). The Dutch version of the National Adult Reading
Test (DART IQ) was conducted as an estimate of verbal intel-
ligence (Schmand et al. 1998).
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One participant in the AMPH group showed a positive
drug screen and was therefore excluded, so the analyses were
performed on 20 controls and 15 AMPH users.
The medical ethics committee of the Academic Medical
Center in Amsterdam approved the study procedures and writ-
ten informed consent was obtained from all subjects and car-
ried out in accordance with the standards of the Declaration of
Helsinki.
Design
Participants were invited to the hospital for two study visits.
On one day they underwent the SPECT scan with dAMPH
administration and on the other day they underwent the MRI
scan with dAMPH administration. The visits were at least one
week apart to allow drug washout and were counterbalanced
within groups. Both for the MRI and the SPECT scan, a can-
nula was inserted in the antecubital vein through which the
dAMPH was administered (0.3 mg/kg) during 2 min, follow-
ed by 15 ml saline to flush (Fig. 1).
SPECT acquisition and analysis
Each subject received an intravenous injection of 180 MBq
[123I]IBZM (80 MBq bolus followed by constant infusion of
20 MBq for 5 consecutive hours). Subjects underwent two
[123I]IBZM SPECT scans, using the sustained equilibrium/
constant infusion technique, to assess baseline striatal DA
D2/3 receptor availability and the decrease in D2/3 receptor bind-
ing after the dAMPH challenge, which provides an index of
DA release (Kegeles et al. 1999). The radioligand [123I]IBZM,
which binds with high affinity to DA D2/3 receptors, was pre-
pared by GE Healthcare (Eindhoven, The Netherlands).
Participants received potassium iodide tablets prior to the
SPECTsession to block thyroid uptake of free radioactive iodide.
Images were acquired on a brain-dedicated SPECT system
(Neurofocus 810, Inc., Medfield, Massachusetts, USA) with
the following parameters: matrix: 64 × 64, energy window:
135–190 keV, slice thickness: 5 mm, acquisition time per
slice: 300 s, number of slices: 12. SPECT images were
corrected for attenuation and reconstructed using iterative al-
gorithms, as earlier described (Booij et al. 1997; Boot et al.
2008). Binding potential (BPND) was calculated as follows:
(mean striatal binding – mean binding occipital cortex)/mean
binding occipital cortex. Standard templates with fixed ROIs
were positioned on the striatum and occipital cortex (reflecting
non-specific binding), as earlier described (Booij et al. 1997;
Boot et al. 2008; Figee et al. 2014). dAMPH-induced decrease
in [123I]IBZM BPND, used as a proxy for DA release, was
expressed as a % of the pre-dAMPHBPND (Booij et al. 1997).
FMRI acquisition
Imaging was performed on a 3-Tesla Ingenia scanner (Philips,
Best, The Netherlands) equipped with a 16-channel head coil.
A T1-weighted anatomical scan was acquired for registration
purposes. For the rs-fMRI scan with blood-oxygenation level-
dependent (BOLD) contrast, 130 whole brain volumes of
T2*-weighted gradient echo planar images (EPI) were obtain-
ed with the following scan parameters: TR/TE 2300/25 ms;
flip angle 80°; FOV = 220 × 220 × 117; 39 slices; voxel size
2.3 × 2.3 × 3 mm, SENSE 2.4. The subjects underwent the
rs-fMRI scan before dAMPH administration and approxi-
mately 30 min post-dAMPH. In the time between the 2
resting-state scans the subjects underwent an arterial spin la-
beling (ASL) scan. Subjects were instructed to keep their eyes
open and let their mind wander.
FMRI analysis
ICA network extraction and connectivity analyses
RS-fMRI data were preprocessed using tools from the FMRIB
Software Library (Smith et al. 2004). Brain tissue was extracted
for both anatomical and functional images using the brain ex-
traction tool (BET). Functional data were motion corrected, spa-
tially smoothed with a Gaussian kernel of 5 mm FWHM and
high-pass temporal filtering at 0.1 Hz was applied. In addition,
single session independent component analysis (ICA) was per-
formed to prepare the data for FMRIB’s ICA-based Xnoiseifier
(FIX) (Griffanti et al. 2014; Salimi-Khorshidi et al. 2014) to
denoise the rs-fMRI data. Prior to analysis, all functional images
were first registered to the high-resolution anatomical image
(BBR) and subsequently to standard stereotactic space (2 mm,Fig. 1 Timeline study protocol
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MNI152 template; Montreal Neurological Institute, Montreal
QC) using affine transformation. Subsequently, the denoised
data were used to investigate RS networks in our groups using
multi-session ICAwith temporal concatenation (as implemented
in FSL MELODIC, Beckmann and Smith 2004). Automatic
dimensionality estimation was used to estimate the number of
components extracted. In addition to the CST network, we ex-
plored 7 networks for further analysis based on their involve-
ment in higher-order cognitive processes and/or DA-ergic func-
tion or DA-associated pathologies (Cole et al. 2013). These
networks will be referred to as the (i) left-lateralised fronto-
parietal network (lFPN) (ii) right-lateralised fronto-parietal net-
work (rFPN) (iii) anterior default mode network (aDMN) (iv)
posterior default mode network (pDMN) (v) ventral default
mode network (vDMN) (vi) inferior salience/executive network
(iSEN) (vii) dorsal salience/executive network (dSEN). For
those eight networks, the set of spatial maps from the group-
average analysis was used to generate subject-specific versions
of the spatial maps, and associated time-series, using dual re-
gression with variance normalization (Beckmann et al. 2009;
Filippini et al. 2009). First, for each subject, the group-average
set of spatial maps was regressed (as spatial regressors in a
multiple regression) into the subject’s 4D space-time dataset.
This results in a set of subject-specific time-series, one per
group-level spatial map. Next, those time-series were regressed
(as temporal regressors, again in a multiple regression) into the
same 4D dataset, resulting in a set of subject-specific spatial
maps, one per group-level spatial map. To assess baseline group
differences, the 4D files for each network were then analyzed
using non-parametric permutation testing (5000 permutations)
with a two-sample t-test using the FSLRandomise tool (Winkler
et al. 2014). To assess the effect of drug and the interaction effect
of drug and group, we calculated difference values of the param-
eter estimates within subjects first using fslmaths, and then per-
formed a one-sample t-test and a two-sample t-test respectively,
again using Randomise. All analyses were initially thresholded
at p-value <0.05 with a family wise error (FWE) correction
using threshold free cluster enhancement (TFCE) (Smith and
Nichols 2009).
Comparison of changes in RS FC and DA release
The 4D files comprising subject-specific spatial maps of
voxelwise connectivity with the CST that were obtained from
the dual regression analysis, were used to assess the correlation
between changes in RS FC and striatal DA release following
acute dAMPH administration. We examined specifically this
network because it incorporated the striatum, the brain region
in which we measured DA release with SPECT, and because
dAMPH is thought to exert its greatest effects in the basal ganglia
(due to its intense DA-ergic input). A striatal mask was created
for the FC map using the MNI structural atlas (Collins et al.
1995).We tested whether individual differences in RS FCwithin
this striatal mask were significantly positively or negatively cor-
related with DA release as measured with [123I]IBZM SPECT
within the same striatal mask in the CST using voxelwise non-
parametric permutation testing as implemented in Randomise,
with 5000 permutations and 5 mm variance smoothing. Voxels
were considered significant at p-value <0.05 with a FWE correc-
tion for multiple comparisons using TFCE.
Effects of heart rate of RS FC
Changes in heart rate (HR) have been found to influence the
BOLD signal, especially near large vessels, and consequen-
tially influence FC in RSNs (Khalili-Mahani et al. 2013).
Dopaminergic drugs such as dAMPH are known to increase
HR and blood pressure (Lile et al. 2011). Although FIX
denoises the data and thereby removes a lot of physiological
variation, it has been shown that areas of physiological varia-
tion can overlap with our RSNs of interest. Therefore, we
decided to repeat our analyses using average HR as a covari-
ate. HRwas monitored during theMRI scan session using a 4-
lead vector cardiogram (VCG) signal and data were extracted
using an in house MATLAB script. Five of our HR measure-
ments were missing and they were imputed with the average
HR of the group and session the scan belonged to.
Results
Demographics
Demographics and AMPH use are provided in Table 1. There
were no significant differences in the age (t(33) = 0.04,
p = 0.97) and IQ (t(33) = −0.07, p = 0.95) between both groups.
In addition to AMPH, the user group also contained more
smokers and cannabis users and used significantly more alco-
hol (U = 214.50, p = 0.03), MDMA (U = 300.00, p < 0.01)
and cocaine (U = 280.00, p < 0.01) than our control group.
The highest score on the DUDIT amongst AMPH users was
16, well below the cut-off score of 25 of probable drug depen-
dence (Voluse et al. 2012). The AMPH users typically used
AMPH as a powder, with the main routes of administration
being inhalation or by dissolving it in a drink.
Effect of acute dAMPH administration on RS FC patterns
We found a significant main effect of dAMPH challenge on
FC patterns in a small cluster in the ACC with the CST net-
work (Fig. 2; Table 2). In addition, in exploratory analyses,
multiple monoaminergic networks showed reduced FC fol-
lowing dAMPH administration (Fig. 3; Table 2). The dSEN
showed decreased connectivity to the anterior cingulate cortex
and left middle frontal gyrus, bilaterally, after dAMPH admin-
istration. On the other hand, the iSEN showed decreases in the
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left precentral gyrus. Additionally, pDMN (and to a lesser
extent vDMN) showed very strong reductions in connectivity,
mostly with the posterior cingulate node of this network. No
significantly different FC patterns were found within the
lFPN, rFPN and aDMN.
We found a trend significant increase in HR during the rest-
ing state scan after dAMPH administration (t(33) = −1.80,
p = 0.08). We did not find any significant changes between
the analyses with HR as a covariate when compared to the
analyses without covariate.
Effect of chronic dAMPH on RS FC patterns
The recreational AMPH users did not differ significantly from
the control group in their resting-state FC patterns, nor in their
response to an acute dAMPH challenge. In Fig. 2 and Fig. 3
the differences in Z-scores of both groups before and after
dAMPH are shown separately.
RS FC associated with striatal D2/3 receptor availability
and DA release
We previously reported reductions in DA release in the current
cohort of AMPH users compared to controls (Schrantee et al.
2014). In line with this, acute dAMPH-induced changes in
resting-state FC between the CST network and the striatum
were positively associated with extent of striatal DA release
(Fig. 4) in both controls and AMPH users. Although the cor-
relation coefficient between DA release and CST FC resting-
state connectivity did not differ between AMPH users and







Age (y)1 21.10 ± 2.77 21.07 ± 1.49 0.97
IQ1 104.10 ± 8.49 104.27 ± 5.02 0.95
Drug use
Amphetamine use lifetime (g)2 – 18 ± 28 NA
occasions – 40 ± 60 NA
average dose (g) – 0.25 ± 0.3 NA
age of onset (y) – 18 ± 2 NA
MDMA use (occasions)2 0 ± 0 6 ± 1 <0.01
Cocaine use (occasions)2 – 2 ± 3 <0.01
Nicotine use (number of smokers) 0 9 NA
Nicotine use (cig/week)2 – 10 ± 2 <0.01
Cannabis use (number of users) 1 9 NA
Alcohol use (units/week)2 6.75 ± 14 14 ± 17 0.03
1 values represent mean ± standard deviations with Student’s t-test
2 values represent median ± interquartile range with Mann–Whitney U-test
Fig. 2 dAMPH induces network-specific changes in FC in CST.
dAMPH induces network-specific changes in CST network FC. Left:
Axial slices of RSN maps extracted with ICA. Middle: Z-scores of
connectivity with RSN for the largest cluster for both controls (white)
and users (grey), pre- and post-dAMPH administration. Both users and
controls display a decrease in connectivity with the RSN following
dAMPH. There was no significant interaction between group and
dAMPH administration on RSN connectivity. Right: Brain regions
displaying significant dAMPH-induced reductions in connectivity with
the RSN, for all subjects (P < 0.05, FWE corrected). Slices in all figures
displayed in radiological convention; coordinates provided in MNI
standard space
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controls (F(1,28) = 0.01, p = 0.91), in AMPH users it was
displaced to the left, indicating more negative or blunted re-
sponses to dAMPH in this group. In AMPH users CST FC
correctly identified blunted DA release in nearly all cases, but
in more than half of the control subjects with a positive DA
release (Fig. 4). Post-hoc, we also determined whether striatal
changewas negatively associatedwith change in ACCRS FC,
but this correlation was only apparent at a trend level
(r = −0.25, p = 0.07). As expected, we did not find a correla-
tion between DA release and baseline RS FC. We also did not
observe any correlation between baseline striatal DA D2/3 re-
ceptor availability and baseline striatal connectivity with the
CST network either.
Discussion
The present study demonstrates that acute dAMPH administra-
tion reduced connectivity within the CST network and that
striatal DA release, but not baseline striatal DA D2/3 receptor
availability, was associated with changes in striatal resting-state
connectivity in this network. In addition to the CST, large effects
of acute dAMPH administration were observed in the salience
executive networks and default mode networks. Contrary to
our hypothesis, we did not observe a group difference in
dAMPH-induced changes in RSNs.
The cortex, striatum and thalamus are connected by means
of large-scale parallel loops with direct monosynaptic connec-
tions from the cortex to the striatum and indirect, polysynaptic
connections from the striatum, through the thalamus and back
to the cortex (Shepherd 2013). This wiring is thought to be
crucial for its role in cognition and motor function and DA
has been shown to modulate these connections (Cole et al.
2013; Honey et al. 2003). Indeed, we found a small cluster in
the ACC that showed reduced connectivity with the CST net-
work following dAMPH administration. This is in accordance
with other studies, showing that drugs that increase DA release
or elevate DA levels (such as MPH and L-DOPA respectively)
decrease FC within regions of the CST network. For instance,
L-DOPA administration has also been found to reduce connec-
tivity of the ACCwith a CST network (Cole et al. 2013). Honey
et al. (2003), demonstrated that MPH, a DATand noradrenaline
transporter blocker, reduced connectivity between the caudate
nucleus and the midbrain, without showing an effect on the
connectivity between the caudate nucleus and the thalamus.
Similarly, Mueller et al. (2014) reported a decrease in cortical
and subcortical components of the CST network following
MPH. In addition, Ramaekers et al. (2013) found reduced con-
nectivity following MPH administration between the ventral
and dorsal striatum, as well as between the ventral striatum
and the medial prefrontal cortex (mPFC). Konova et al.
(2013) also focused on the CST network but found opposite
effects, with MPH decreasing intra-striatal connectivity, but in-
creasing cortico-striatal connectivity. However, this was in a
sample of cocaine dependent subjects, which has been shown
to have altered connectivity patterns (Konova et al. 2013).
We also demonstrated that dAMPH-induced striatal DA
release was associated with changes in CST resting-state FC
Table 2 Brain regions displaying
significant decreases of FC
following dAMPH, relative to
baseline
RSN of interest Brain region Voxels Max t MNI coordinates
x y z
CST BL paracingulate gyrus, anterior cingulate gyrus 49 4.71 0 40 28
vDMN R posterior cingulate gyrus 68 5.53 8 −48 6
pDMN BL precuneous cortex, posterior cingulate cortex 4945 8.35 −2 −70 34
R central opercular cortex 150 4.88 40 −70 48
L middle temporal gyrus 123 4.09 −45 −58 8
L planum temporale 107 4.48 −64 −26 16
L middle temporal gyrus 95 4.43 −66 −44 0
L supramarginal gyrus, anterior 44 3.42 −62 −36 36
dSEN BL anterior cingulate cortex 1387 6.51 2 20 30
L middle frontal gyrus 342 6.2 −32 38 44
R supramarginal gyrus, anterior 149 4.71 64 −28 32
iSEN L precentral gyrus 982 5.49 −62 −10 10
R temporal pole 168 5.05 52 12 −4
L middle temporal gyrus 92 4.63 60 −52 8
R supramarginal gyrus 51 5.27 −62 −26 42
CST, cortico-striatal-thalamic network; dSEN, dorsal salience executive network; iSEN, inferior salience exec-
utive network; pDMN, posterior default mode network; vDMN, ventral default mode network; clusters >40
voxels are reported
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in the striatum following dAMPH administration. This is in
line with animal studies in which microdialysis measurements
of striatal DA release are associated with BOLD and CBF
changes following dAMPH administration (Chen et al.
1997). Our correlational analysis was performed for the
striatum, because this is the brain region where we also mea-
sured DA release, whereas differences in RS FC following
dAMPH administration were measured for the whole brain.
The neuronal effects of dAMPH are thought to originate main-
ly from the basal ganglia, as dAMPH increases extracellular
Fig. 3 Exploratory analyses of dAMPH induces network-specific
changes in FC. dAMPH induces network-specific changes in resting-
state connectivity. A-D, left: Axial slices of RSN maps extracted with
ICA. A-D, middle: Z-scores of connectivity with RSN for the largest
cluster for both controls (white) and users (grey), pre- and post-dAMPH
administration. Both users and controls display a decrease in connectivity
with the RSN following dAMPH. There was no significant interaction
between group and dAMPH administration on RSN connectivity. A-D,
right: Brain regions displaying significant dAMPH-induced reductions in
connectivity with the RSN, for all subjects (P < 0.05, FWE corrected).
Slices in all figures displayed in radiological convention; coordinates
provided in MNI standard space
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DA primarily in these regions (Chen et al. 1997). Yet, in our
study, we did not find any subcortical areas that showed al-
tered connectivity following dAMPH administration.
However, dopaminergic and noradrenergic (NA) terminals
are also widely distributed in cortical areas (Lewis et al.
1987). Indeed, a recent microdialysis study showed that ad-
ministration of dAMPH increases both DA and NA in the
prefrontal cortex, but only DA in the striatum (Rowley et al.
2014). As such, modulation of RSNs in the striatum may be
mainly determined by DA release, whereas cortical RS FC is
both dependent on changes of DA and NA. This could also
explain why we find a decrease in ACC connectivity, despite
increases in striatal DA release. This is further supported by
the inverted-U hypothesis of DAergic modulation, suggesting
that there is an optimal level of DAergic stimulation, with both
too little and too much DA negatively impacting behavior.
Indeed, previous studies have already shown that DA modu-
lations can induce inverted-U relationships in cortical FC pat-
terns (Cole et al. 2013). Therefore, it is conceivable that FC
decreases in the cortex when DA release is acutely increased
to a large extent in subcortical areas. In this context, it would
be very interesting to study dose–response relationships of
DA modulation on RS FC.
Contrary to what we expected, no significant group differ-
ences nor any interaction effects on RS FC patterns were
found, even though the groups under study differed markedly
on baseline striatal DAD2/3 receptor availability and dAMPH-
induced DA release, as we reported elsewhere (Schrantee
et al. 2014). This is possibly due to the sensitivity of rs-
fMRI measurements to pick up regional DA alterations.
SPECT is a direct method to investigate DAergic receptor
binding, whereas rs-fMRI is an indirect tool to assess temporal
coherent activity between brain regions and could therefore be
less sensitive to small DA alterations in part of a network. This
is in contrast with studies reporting alterations in CSTconnec-
tivity in subjects with other drugs of abuse acting on the DA
system, such as cocaine and METH (Gu et al. 2010; Kohno
et al. 2014; Konova et al. 2013). The largest difference be-
tween those studies and the present one is that those subjects
suffered from substance dependence, whereas our subjects
were typically recreational users. It is extremely difficult to
disentangle the effects of addiction per se and neurotoxicity
of the drug that subjects are addicted to. Yet, it is possible that
addiction in itself induces changes in resting state connectivity
that are not evident in recreational users of a drug. For exam-
ple, neurobiological correlates of intoxication differ from
those of craving and compulsory drug administration
(Goldstein and Volkow 2002; Koob and Volkow 2010). A
related explanation might be that although our users displayed
alterations in DA release, compensatory changes in the CST
loops may have ‘buffered’ alterations in resting state connec-
tivity. Such compensatory measures may be sufficient to
maintain normal CST connectivity in case of recreational
use, but might fail when subjects become addicted to a drug.
Although no studies have directly compared RS FC between
recreational use and addiction, the transition phase from abuse
to addiction has been associated with compensatory mecha-
nisms (Kalivas and Volkow 2005).
In addition to acute changes in the CST network, we found
reduced connectivity in DMNs and SENs following dAMPH
administration. This is concordance with other studies that
also found changes in connectivity after DA drug administra-
tion in networks outside the CST loops. In our study, the most
prominent effect of acute dAMPH on FC was in the DMN, a
network in which connectivity is suppressed during task per-
formance. We found reductions of connectivity primarily in
posterior parietal regions. Failure to inhibit DMN activity dur-
ing task performance is associated with worse behavioral per-
formance (Weissman et al. 2006). Our findings are in concor-
dance with a study by Kelly et al. (2009) that showed that L-
DOPA, a DA precursor, decreased DMN activity, and
Nagano-Saito et al. (2008) that demonstrated that DA deple-
tion increased DMN activity in healthy controls. In addition to
changes in DMN connectivity we also found reductions in
connectivity within salience-executive networks (dSEN and
iSEN), including mostly frontal areas. Salience-executive net-
works are thought to play a role in reward and cognitive pro-
cessing (Seeley et al. 2007). These findings are in line with
Fig. 4 Effect of DA release on changes in CST connectivity with the
striatum. (A) dAMPH-induced changes in functional connectivity are
positively associated with dAMPH-induced DA release in the striatum
(P < 0.05, FWE corrected). Slices are displayed in radiological
convention; coordinates provided in MNI standard space. (B) Both
users and controls display this positive correlation and there is no
significant difference between the slopes
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task fMRI literature showing that administration of oral
dAMPH reduces activation in a monetary incentive delay task
(Knutson et al. 2004). However, Cole et al. (2013) reported no
changes in SEN networks following L-DOPA administration,
whereas Mueller et al. (2014) found increased connectivity of
SENs with the visual cortex, but decreased connectivity with
the cerebellum and thalamus. Although we found large reduc-
tions of RS FC in DMN and SEN’s, these analyses were ex-
ploratory in nature and therefore we cannot draw strong con-
clusions from them. Still, the large effects observed in these
networks, highlight the importance of whole brain analyses
for rs-fMRI data. Networks in the brain are not single entities,
but can influence other networks and work in close concor-
dance. It would be interesting for further research to assess the
effects of DA drugs on between-network connectivity (Smith
et al. 2013).
This study investigated the effects of dAMPH administra-
tion on resting-state BOLD signal fluctuations. The BOLD
signal is influenced by a large number of factors including
CBF, cerebral blood volume, and oxygenation. dAMPH has
been shown to be a vasoconstrictive agent systemically and in
the brain by DA receptors on microvessels (Choi et al. 2006).
Therefore, we cannot exclude vascular contributions (unrelat-
ed to neuronal effects) to the acute dAMPH-induced changes
in RS FC as reported here. In addition, in this study we ad-
ministered the drug intravenously rather than orally, as most
studies so far have done. Intravenous administration induces a
large strain on the cardiovascular system which may influence
the BOLD response (Heal et al. 2013). However, we observed
that the large physiological effects are primarily present
directly following administration and have largely sub-
sided at the time of our rs-fMRI sequence 30 min later
(Heal et al. 2013). In addition, adding HR as a covari-
ate in our statistical analysis did not affect our results.
Therefore, it is unlikely that cardiovascular changes
contributed to the acute dAMPH-induced RSN modula-
tions. In addition, we used FIX to remove residual
physiological variation and motion (Griffanti et al.
2014). So, the potential confounding cardiovascular ef-
fects were reduced to a minimum in this study. In ad-
dition, in between resting-state scans subjects underwent
a resting-state ASL scan, which means that there were
no confounding effects of cognitive tasks that could
influence subsequent resting-state FC (Gordon et al.
2014).
In this study, the participants received a dAMPH challenge
twice, which could potentially impose an order effect. To ac-
count for this, we counterbalanced the visits within groups,
with half of the subjects first undergoing the SPECTscans and
the other half first undergoing the MRI scan. One more limi-
tation of this study is that subjects always underwent the
dAMPH scan after the baseline scan, which could induce ex-
pectancy effects (Gundersen et al. 2008). However, subjects
were aware that they would not yet receive the dAMPH chal-
lenge until the ASL scan 15 min later. In addition, if the an-
ticipation differed between AMPH users and controls, one
would expect AMPH users to have more anticipation of re-
ward and therefore more [123I]IBZM displacement than the
controls. Yet, we observed a blunted response in the AMPH
users compared to controls. Nevertheless, future studies could
assess the expectancy effects by including a placebo condi-
tion. In addition, an inherent limitation to studies investigating
recreational drug use is polydrug use. Indeed, in our sample,
AMPH users also used significantly more other drugs and we
can therefore not exclude that our results are due to other drug
use. However, the subjects underwent a drug screening prior
to the scans, which excludes acute effects of other drugs of
abuse on our results. In addition, the effect of acute adminis-
tration on the CST network is consistent with studies investi-
gating the effect of MPH and L-DOPA on CST FC. However,
polydrug use could have increased variation within the
dAMPH user group and this could have resulted in a lower
power to detect group differences. In addition, many different
analysis techniques are employed, but comparisons between
for example ICA and seed-based approaches have not found
significant differences in reproducibility and ability to detect
resting-state networks (Franco et al. 2013; Hale et al. 2015). In
fact, for inter-individual differences ICA-based approaches
may be more sensitive than seed-based approaches (Smith
et al. 2014), which is reflected in the association we observed
between striatal DA release and RS FC. Yet, it is possible that
other techniques are more sensitive than ICA-based tech-
niques to detect group differences in specific subcortical
DA-ergic regions, but this postulate remains to be tested.
Another potential limitation is that our resting-state scan
contained 130 volumes, which is a relatively short scan.
However, studies have shown that resting state scans of 5 up
to 13 min provide reliable estimates of resting state connec-
tivity networks (Birn et al. 2013). Although our scan of 5 min
falls within that time window, it is possible that longer resting-
state scans (up to 12 min) provide more information and could
thus be more sensitive to detect the difference between our
recreational dAMPH users and controls. This would be an
interesting topic for further research.
Conclusion
In conclusion, we demonstrate that acute dAMPH reduces RS
FC within multiple RSNs and that individual variation in DA
release following an acute challenge with dAMPH, predicts
changes in resting-state FC. These results suggest an impor-
tant role for both DA (and NA) in the modulation of RS FC by
dAMPH. However, we did not find significant group differ-
ences in RS FC, possibly due to lack of sensitivity or compen-
satory mechanisms for reduced DA release.
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